During the past decade, Access Clinical Trials, Inc. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 7 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Access Clinical Trials, Inc." #1 sponsor was "Emalex Biosciences Inc." with 3 trials, followed by "Eisai Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Shire" with 2 trials sponsored and "AcelRx Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Access Clinical Trials, Inc." #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Norgine" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Access Clinical Trials, Inc." are "Attention Deficit Hyperactivity Disorder (ADHD)" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Treatment of Migraine" (1 trials), "Arthritis, Rheumatoid" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "Access Clinical Trials, Inc." in a lesser frequency.

Most popular intervention types in "Access Clinical Trials, Inc." are "Drug" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ecopipam" (2 trials), "Rufinamide" (2 trials), "SHP465" (2 trials) and "5% dextrose in water" (1 trials). Other intervention names were less common.

The vast majority of trials in "Access Clinical Trials, Inc." are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Access Clinical Trials, Inc.". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Access Clinical Trials, Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Access Clinical Trials, Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".